Clinical Trial Update: Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCT [NA]

View source ↗

Summary

This completed clinical trial evaluates whether FDG PET imaging can predict residual disease. It also examines subsequent relapse in patients with non-Hodgkin l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Non-hodgkin Lymphoma

Snippet

Sponsor: King Faisal Specialist Hospital & Research Center | Conditions: Lymphoma, Non-Hodgkin, Hodgkin Disease | NA | Status: COMPLETED